|
|
ALPS Group Inc
NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/02/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization97.18 mln
Earnings Date07/03/2026
Key Fundamentals
EPS-0.02
RPS0.02
ROIC-36.89
ROA-36.40
EBITDA, mln-2.49
EV / EBITDA-43.01
EV / EBIT-43.01
Revenue, mln3.37
EV / Revenue31.72
Financial Strength
Altman Z-Score3.87
Piotroski F-Score
5
/ 9
Beneish M-Score-2.5
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-9.38% |
8
/ 100
 |
| 1 Month |
-14.9% |
16
/ 100
 |
| 2 Months |
-42.82% |
6
/ 100
|
| 6 Months |
-34.69% |
14
/ 100
 |
|
| |
